Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 2. On the role of correlation analysis in decision making in drug modification. Toxicity quantitative structure-activity relationships of 1-(X-phenyl)-3,3-dialkyltriazenes in mice
- 31 May 1978
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 21 (6), 574-577
- https://doi.org/10.1021/jm00204a013
Abstract
A series of 11 triazenes (X-C6H4N = NNRCH3) was characterized for toxicity in mice (LD50). The quantitative structure-activity relationship (QSAR) obtained for toxicity was compared with the QSAR for antitumor activity [mouse L1210 leukemia]. The close correspondence of the 2 QSAR leaves essentially no means for the synthesis of more potent, less toxic triazenes.This publication has 5 references indexed in Scilit:
- Antitumor 1-(X-aryl)-3,3-dialkyltriazenes. 1. Quantitative structure-activity relationships vs L1210 leukemia in miceJournal of Medicinal Chemistry, 1978
- Tumour inhibitory triazenes: Structural requirements for an active metaboliteBiochemical Pharmacology, 1976
- INTERACTION OF CARCINOGEN 3,3-DIMETHYL-1-PHENYLTRIAZENE WITH NUCLEIC-ACIDS OF VARIOUS RAT TISSUES AND EFFECT OF A PROTEIN-FREE DIET1976
- FURTHER INVESTIGATION ON CARCINOSTATIC ACTIVITY OF 4(OR 5)-AMINOIMIDAZOLE-5(OR 4)-CARBOXAMIDE DERIVATIVES - STRUCTURE-ACTIVITY RELATIONSHIP1968
- Triazenes as Inhibitors of Mouse Sarcoma 180.Experimental Biology and Medicine, 1955